Pro-level noise cancellation, amazing battery life, deep bass, and supreme comfort make these among the best $249 headphones anywhere.

Optical illusions are great fun, and they fool virtually everyone. But have you ever wondered if you could train yourself to unsee these illusions? Our latest research suggests that you can.

Optical illusions tell a lot about how people see things. For example, look at the picture below.

The Ebbinghaus illusion.
Credit:
Hermann Ebbinghaus

The two orange circles are identical, but the one on the right looks bigger. Why? We use context to figure out what we are seeing. Something surrounded by smaller things is often quite big. Our visual system takes context into account, so it judges the orange circle on the right as bigger than the one on the left.

Read full article

Comments

Google parent Alphabet has agreed to buy cyber security start-up Wiz for $32 billion, the biggest acquisition in the search group’s history, according to Financial Times, which cites sources. From the report: Alphabet held talks over a $23 billion acquisition of Wiz last year, although the negotiations collapsed after some of the cyber security company’s directors and investors became worried about antitrust hurdles.

The deal, which will rank as the biggest deal of the year so far, will be announced on Tuesday morning, a person said. It will probably still face scrutiny from the Federal Trade Commission under President Donald Trump, whose new chair Andrew Ferguson has maintained guidelines giving the agency the ability to block large deals used by his predecessor Lina Khan.

Read more of this story at Slashdot.

There’s a new Google AI model in town, and it can generate or edit images as easily as it can create text—as part of its chatbot conversation. The results aren’t perfect, but it’s quite possible everyone in the near future will be able to manipulate images this way.

Last Wednesday, Google expanded access to Gemini 2.0 Flash’s native image generation capabilities, making the experimental feature available to anyone using Google AI Studio. Previously limited to testers since December, the multimodal technology integrates both native text and image processing capabilities into one AI model.

The new model, titled “Gemini 2.0 Flash (Image Generation) Experimental,” flew somewhat under the radar last week, but it has been garnering more attention over the past few days due to its ability to remove watermarks from images, albeit with artifacts and a reduction in image quality.

Read full article

Comments

A massive $900 limit on trade-in credit, or $300 off without trade, are the latest incentives to make the Galaxy S25 Ultra your favorite smartphone ever.

Firefly Aerospace’s Blue Ghost science station accomplished a lot on the Moon in the last two weeks. Among other things, its instruments drilled into the Moon’s surface, tested an extraterrestrial vacuum cleaner, and showed that future missions could use GPS navigation signals to navigate on the lunar surface.

These are all important achievements, gathering data that could shed light on the Moon’s formation and evolution, demonstrating new ways of collecting samples on other planets, and revealing the remarkable reach of the US military’s GPS satellite network.

But the pièce de résistance for Firefly’s first Moon mission might be the daily dose of imagery that streamed down from the Blue Ghost spacecraft. A suite of cameras recorded the cloud of dust created as the lander’s engine plume blew away the uppermost layer of lunar soil as it touched down March 2 in Mare Crisium, or the Sea of Crises. This location is in a flat basin situated on the upper right quadrant of the side of the Moon always facing the Earth.

Read full article

Comments

The tusk may have belonged to a Columbian mammoth, an Ice Age species that disappeared over 11,000 years ago.

HR software startup Rippling has sued competitor Deel, alleging that Deel orchestrated corporate espionage by recruiting an employee within Rippling to steal trade secrets, including customer data, sales strategies, and internal records. The lawsuit (PDF) claims the spy shared confidential information with Deel executives and a reporter, leading to legal action under the Racketeer Influenced and Corrupt Organizations (RICO) Act. Deel denies wrongdoing and plans to counter the claims. CNBC reports: The two startups are among the most world’s most valuable. Investors valued Rippling at $13.5 billion in a funding round announced last year, while Deel told media outlets in 2023 that it was worth $12 billion. Deel ranked No. 28 on CNBC’s 2024 Disruptor 50 list. “Weeks after Rippling is accused of violating sanctions law in Russia and seeding falsehoods about Deel, Rippling is trying to shift the narrative with these sensationalized claims,” a Deel spokesperson told CNBC in an email. “We deny all legal wrongdoing and look forward to asserting our counterclaims.”

Rippling confirmed its findings earlier this month. The company’s general counsel sent a letter to three Deel executives that referred to a new Slack channel, and the Deel spy quickly looked for it. Rippling subsequently served a court order to the spy at its office in Dublin, Ireland requiring him to preserve information on his mobile phone. “Deel’s spy lied to the court-appointed solicitor about the location of his phone, and then locked himself in a bathroom — seemingly in order to delete evidence from his phone — all while the independent solicitor repeatedly warned him not to delete materials from his device and that his non-compliance was breaching a court order with penal endorsement,” Rippling said in Monday’s filing. “The spy responded: ‘I’m willing to take that risk.’ He then fled the premises.” “We always prefer to win by building the best products and we don’t turn to the legal system lightly,” Parker Conrad, Rippling’s co-founder and CEO, said in a Monday X post. “But we are taking this extraordinary step to send a clear message that this type of misconduct has no place in our industry.”

Read more of this story at Slashdot.

A newly FDA-approved form of adaptive deep-brain stimulation (DBS) for Parkinson’s disease adjusts electrical stimulation in real time based on an individual’s brain signals, improving symptom control and reducing medication dependence. Scientific American: For decades, Keith Krehbiel took high doses of medications with a debilitating side effect — severe nausea — following his diagnosis with early-onset Parkinson’s disease at age 42 in 1997. When each dose wore off, he experienced dyskinesia — involuntary, repetitive muscle movements. In his case, this consisted of head bobbing and weaving. Krehbiel is among one million Americans who live with this progressive neurological disorder, which causes slowed movements, tremors and balance problems. But soon after surgery to implant electrodes into specific areas of his brain in 2020, his life dramatically improved. “My tremor went away almost entirely,” says Krehbiel, now age 70 and a professor emeritus of political science at the Stanford Graduate School of Business, whose Parkinson’s symptoms began at age 40 and were initially misdiagnosed as repetitive stress injury from computer use. “I reduced my Parkinson’s meds by more than two thirds,” he adds. “And I no longer have a sensation of a foggy brain, nor nausea or dyskinesia.”

Krehbiel was the first participant to enroll in a clinical trial testing a new form of deep-brain stimulation (DBS), a technology that gained approval from the U.S. Food and Drug Administration for Parkinson’s tremor and essential tremor in 1997 (it was later approved for other symptoms and conditions). The new adaptive system adjusts stimulation levels automatically based on the person’s individual brain signals. In late February it received FDA approval for Parkinson’s disease “based on results of the international multicenter trial, which involved participants at 10 sites across a total of four countries — the U.S., the Netherlands, Canada and France. This technology is suitable for anyone with Parkinson’s, not just individuals in clinical trials, says Helen Bronte-Stewart, the recent trial’s global lead investigator and a neurologist specializing in movement disorders at Stanford Medicine. “Like a cardiac pacemaker that responds to the rhythms of the heart, adaptive deep-brain stimulation uses a person’s individual brain signals to control the electric pulses it delivers,” Bronte-Stewart says. “This makes it more personalized, precise and efficient than older DBS methods.”

“Traditional DBS delivers constant stimulation, which doesn’t always match the fluctuating symptoms of Parkinson’s disease,” adds neurologist Todd Herrington, another of the trial’s investigators and director of the deep-brain stimulation program at Massachusetts General Hospital. With adaptive DBS, “the goal is to adjust stimulation in real time to provide more effective symptom control, fewer side effects and improved patient quality of life.” Current FDA approval of this adaptive system is for the treatment of Parkinson’s only, not essential tremor, dystonia (a neurological disorder that causes excessive, repetitive and involuntary muscle contractions) or epilepsy, which still rely on traditional, continuous DBS, Herrington says.

Read more of this story at Slashdot.